International Angiology

Size: px
Start display at page:

Download "International Angiology"

Transcription

1 VOLUME 33. AUGUST Suppl. 1 to issue No. 4 International Angiology ABSTRACT BOOK XXVI WORLD CONGRESS OF THE INTERNATIONAL UNION OF ANGIOLOGY Sydney, Australia August 10-14, 2014

2

3 INTERNATIONAL ANGIOLOGY Official Journal of International Union of Angiology, Union Internationale de Phlébologie, Central European Vascular Forum FOUNDER AND EDITOR-IN-CHIEF EMERITUS EDITOR-IN-CHIEF P. BALAS, Athens, Greece A. NICOLAIDES, Nicosia, Cyprus CO-EDITORS A. SCUDERI, Sao Paolo, Brazil (UIP) G. GEROULAKOS, London, UK (Ang. Forum, RSM) J. FAREED, Chicago, USA (IUA) V. STVRTINOVA, Bratislava, Slovakia (CEVF) SPECIALIST COMMITTEE S. A.N. ALAM, Dhaka, Bangladesh F. A. ALLAERT, Dijon, France B. AMANN-VESTI, Zurich, Switzerland P. L. ANTIGNANI, Rome, Italy R. M. BAUERSACHS, Munich, Germany C. CAMPISI, Genoa, Italy A. CARLIZZA, Rome, Italy P. CARPENTIER, Grenoble, France J. CAPRINI, Chicago, USA M. CAZAUBON, Paris, France S. CHENG, Hong Kong, China D. CLEMENT, Ghent, Belgium A. CORNU-THENARD, Paris, France P. DIMAKAKOS, Athens, Greece E. CORRADO, Palermo, Italy L. DAVIDOVIC, Belgrade, Serbia C. DELIS, Athens, Greece C. DELTAS, Nicosia, Cyprus E. DIMAKAKOS, Athens, Greece M. DOBLAS, Toledo, Spain R. DONNELLY, Nottingham, UK D. DUPREZ, Minneapolis, USA B. EKLOF, Råå, Sweden S. ESSAM, Cairo, Egypt J. FLETCHER, Sydney, Australia S. GEORGOPOULOS, Athens, Greece B. GORENEK, Eskisehir, Turkey A. GIANNOUKAS, Larissa, Greece M. GRIFFIN, London, UK J. D. GRUSS, Kassel, Germany H. HAYOZ, Lausanne, Switzerland U. HOFFMANN, Munich, Germany M. HORROCKS, Bath, UK M. K. JEZOVNIK, Ljubljana, Slovenia S. KAKKOS, Patras, Greece P. KALMAN, Chicago, USA E. KALODIKI, London, UK A. KATSAMOURIS, Heraklion, Greece R. KISTNER, Honolulu, USA N. LABROPOULOS, New York, USA B. B LEE, Washington DC, USA C. LIAPIS, Athens, Greece F. H.A. MAFFEI, Sao Paolo, Brazil A. MARKEL, Haifa, Israel S. R. MARQUES, Recife, Brazil R. MARTIN, Bristol, UK P. J. MATLEY, Claremont, South Africa R. MATTASSI, Milan, Italy L. MENDES PEDRO, Lisbon, Portugal F. MIRANDA Jr, Sao Paolo, Brazil J. L. NASCIMENTO Silva, Rio, Brazil L. NORGREN, Örebo, Sweden A. PANAYIOTOU, Nicosia, Cyprus H. PARTSCH, Vienna, Austria Z. PECSVARADY, Budapest, Hungary M. PERRIN, Lyon, France O. PICHOT, Grenoble, France A. PIERIDES, Nicosia, Cyprus A. D. POLYDOROU, Athens, Greece P. POREDOS, Ljubljana, Slovenia E. RABE, Bonn, Germany D. RADAK, Belgrade, Serbia G. H. R. RAO, Minneapolis, USA V. RIAMBAU, Barcelona, Spain X. SCHMID-SCHOEBEIN, San Diego, USA A. SCUDERI, Sorocaba, Brazil F. SPINELLI, Messina, Italy M. SPRYNGER, Liège, Belgium I. STAELENS, Brussels, Belgium J. WALENGA, Chicago, USA H. VANDAMME, Leuven, Belgium Gu YONG-QUAN, Beijing, China N. S. ANGELIDES, Nicosia, Cyprus L. BANFIÇ, Zagreb, Croatia J. BELCH, Dundee, UK H. BOCCALON, Toulouse, France T. BOWER, Rochester, USA M. BRODMANN, Graz, Austria M. CAIROLS, Barcelona, Spain M. CASTRO SILVA, Belo, Horizonte, Brazil M. CATALANO, Milan, Italy E. DIAMANTOPOULOS, Athens, Greece D. DZSINICH, Budapest, Hungary J. FERNANDES E FERNANDES, Lisbon, Portugal REGIONAL EDITORS H. GIBBS, Brisbane, Australia P. GLOVICZKI, Rochester, USA D. HOPPENSTEADT, Chicago, USA S. HOSHINO, Tokyo, Japan E. HUSSEIN, Cairo, Egypt A. JAWIEN, Bydgoszcz, Poland F. KHAN, Glasgow, UK J. J. MICHIELS, Rotterdam, Netherlands M. MIRALLES, Barcelona, Spain S. NOVO, Palermo, Italy J. PANNETON, Rochester, USA J. PERREIRA ALBINO, Lisbon, Portugal E. PILGER, Graz, Austria E. PURAS, Madrid, Spain H. RIEGER, Engelskirchen, Germany K. ROZTOCIL, Praque, Czech Republic T. SASAJIMA, Muroran, Japan H. SHIGEMATSU, Tokyo, Japan R. SIMKIN, Buenos Aires, Argentina V. TRIPONIS, Vilnius, Lithuania J. ULLOA, Bogota, Colombia O. N. ULUTIN, Istanbul, Turkey A. van RIJ, Dunedin, New Zealand M. VELLER, Parktown, South Africa Z. G. WANG, Beijing, China E. ASCER, New York, USA M. AMOR, Nancy, France E. BASTOUNIS, Athens, Greece P. BELL, Leicester, UK G. BIASI, Milan, Italy L. CASTELLANI, Tours, France K. CHERRY, Jr., Rochester, USA M. CHOCHOLA, Praque, Czech Republic F. CRIADO, Baltimore, USA E. B. DIETHRICH, Phoenix, Arizona J. A. DORMANDY, London, UK E. ERACLEOUS, Nicosia, Cyprus I. ERIKSON, Uppsala, Sweden J. R. ESCUDERO, Barcelona, Spain P. FIORANI, Rome, Italy EDITORIAL COMMITTEE A. FROIO, Milan, Italy L. J. GREENFIELD, Ann Arbor, USA J. J. GUEX, Nice, France J. HALLET, Maine, USA M. HENRY, Nancy, France L. HOLLIER, New Orleans, USA P. KALMAN, Chicago, USA M. R. LASSEN, Aalbord, Denmark M. MALOUF, Sydney, Australia P. G. MATTHEWS, Melbourne, Australia M. A. McGRATH, Darlinghurst, Australia D. MIKHAILIDIS, London, UK N. NAKAJIMA, Chiba, Japan W. PAASKE, Aarhus, Denmark S. RAJU, Jackson, USA M. M. SAMAMA, Paris, France J. SCURR, London, UK S. J. SIMONIAN, Annandale, USA C. SPARTERA, L Aquila, Italy F. SPEZIALE, Rome, Italy A. TAKESHITA, Fukuoka, Japan O. THULESIUS, Linkoping, Sweden P. VALE, Sydney, Australia J. L. VILLAVICCENCIO, Bethesda, USA M. YOKOHAMA, Kobe, Japan J. ZHANG, Beijing, China C. K. ZARINS, Stanford, USA R. E. ZIERLER, Seattle, USA EDITORS EMERITUS C. ALLEGRA, Rome, Italy P. MAURER, Munich, Germany ADMINISTRATIVE EDITOR D. BOND, London, UK MANAGING EDITOR A. OLIARO, Turin, Italy

4

5 Abstract Book XXVI World Congress of the International Union of Angiology August 10-14, 2014 SYDNEY, AUSTRALIA Congress President JOHN FLETCHER EDIZIONI MINERVA MEDICA TORINO 2014

6

7 INTERNATIONAL ANGIOLOGY Official Journal of the International Union of Angiology Volume 33 No. 4 (August 2014) C O N T E N T S FREE PAPER SESSION 1 1 Evaluating the intracranial perforating branches by micro angiographic system using a rotating cerium anode C. Tanaka, Y. Ikeya, T. Shizuma, N. Fukuyama, H. Mori 1 An endovascular-first paradigm shift results in superior limb salvage rates S. Thomas, N. Katib, R. Varcoe 2 Covered stents in treating peripheral aneurysms in patients with behcet s disease Z. Sun, H. Wang, Y. Shen, W. Jiang 2 Covered stent for carotid aneurysm in patients with bovine aortic arch A. Bashar, G. Hossain, E. Hakim, N. Mandal, M. Hossain, N. Dey, S. Alam 3 Has carotid artery stenting found its place? a 10-year regional centre perspective. N. Biggs, S. Rangarajan, D. McClure 3 Contemporary epidemiological study of abdominal aortic aneurysm (aaa) in men and women of different ages. a case-control study M. Chabok, M. Farahmandfar, M. Aslam, N. Garbani, A. Manganaro, J. Coltart, A. Nicolaides 3 Vascular complications in intravenous drug abusers. vascular surgeons up against a social scourge in a developing country A. Bashar, G. Hossain, E. Hakim, M. Hossain, N. Mandal, S. Alam 4 Hemolytic anemia in thromboangiitis obliterans; a report of 29 cases B. Fazeli, H. Ravari, M. Akbarin 4 Investigation of disease severity in patients with scleroderma using the lakk-m device F. Adams, J. Millar, S. Sokolovski, J. Belch, E. Rafailov, F. Khan 5 Chronic kidney disease and cardiovascular comorbidities M. Chabok, M. Farahmandfar, M. Aslam 5 The contemporary management and cost-analysis of symptomatic aorto-iliac occlusive disease (AIOD) M. Ahmad, T. Nieto, T. Wilmink, A. Ganeshan, D. Adam, M. Claridge 6 Corrosion resistance and surface evaluation of five selfexpanding nitinol stents used in clinical practice J. Morrison, M. Pelletier, A. Rives, W. Walsh, J. Yang, R. Varcoe FREE PAPER SESSION 2 7 A novel mouse model that reflects human atherosclerotic plaque instability is a unique tool for drug testing and mechanistic discoveries K. Peter, Y. Chen 7 Correlation between carotid plaque burden, carotid intima media thickness (cimt) with heart disease risk factors M. Farahmandfar, M. Chabok, M. Aslam 8 Serum phosphatidylcholine plasmalogen concentrations are strongly predictive of myocardial infarction risk in patients with peripheral artery disease J. Moxon, G. Wong, R. Jones, D. Liu, J. Weir, B. Kingwell, P. Meikle, J. Golledge 8 The association of calf skeletal muscle characteristics with major adverse events in peripheral artery disease D. Morris, J. Moxon, M. Cunningham, J. Golledge Vol Suppl. 1 to No. 4 V

8 9 Early onset aggressive atherosclerotic peripheral arterioocclusive disease. search for the pathogenic factor A. Bashar, E. Hakim, G. Hossain, M. Hossain, N. Mandal, N. Dey, M. Arif, A. Mamun, S. Alam 9 The association of lower extremity performance with cardiovascular and all-cause mortality in patients with peripheral artery disease D. Morris, A. Rodriguez, J. Moxon, M. Cunningham, R. Jones, J. Golledge 10 The 78 kda glucose response protein (grp78) is recruited to the surface of endothelium by interacting with thrombomodulin and it demonstrates antithrombotic activity H. Nandurkar, A. Sharma, X. Zhang, C. Selan, A. Samudra, E. Salvaris, B. Michell, B. Kemp, P. Cowan 10 The ankle cubital d-dimer ratio (acdr) is independent of age and confirms increased pro-thrombotic activity at the site of varicose veins C. Lattimer, E. Kalodiki, G. Geroulakos, J. Fareed, D. Hoppensteadt, D. Syed FREE PAPER SESSION 3 13 Incidence and risk factors of asymptomatic central vein or proximal vein stenosis in acute arteriovenous graft and fistula thrombosis in dialysis patients K. Lawanwong, W. Tirapanich, S. Jirasiritham, S. Leela- Udomlipi, P. Pootrakool, P. Lertsithichai, S. Horsirimanont 13 Carbon dioxide as the primary contrast media in endovascular therapy for preventing renal complications T. Sahu 14 Comparision of vacuum-assisted closure and moist wound dressing in the treatment of diabetic foot ulcers H. Ravari, M. Saeed Modaghegh, G. Kazemzade, H. Ghoddusi Johari, A. Mohammadzadeh, A. Sangaki, M. Vahedian Shahrodi 14 Full field laser perfusion imager (FLPI) and post occlusive reactive hyperaemia (PORH) for the assessment of skin microvascular endothelial function? F. Adams, J. Belch, F. Khan 15 Investigating the effect of changing air pressure on microvenous function J. Marx, A. Granot, I. Carlisle, O. Hirth 15 French cross-cultural translation and adaptation of the ausviquol. australian disease-specific quality of life questionnaire (QoL) for peripheral arterial disease (PAD) S. Zerrouk, J. Renaudin, C. Rotonda, E. Chou, P. Julia FREE PAPER SESSION 4 17 Comparison of trauma patients with or without runoff in angiographic findings H. Ravari, M. Pezeshki Rad, A. Bahadori, O. Ajami 17 Adjunctive techniques to facilitate endovascular repair of aortic dissection of the arch and its branches. hybrid repairs and chimneys S. Chang, F. Kun 18 Laser-doppler flowmetry. a practical, predictive tool of free flap behaviour in breast reconstruction surgery? J. Butterworth, M. Aslam, A. Fitton 18 A new method of preoperative marking for reconstructive surgery using a sural-medial perforating flap. a duplex ultrasound study S. Zerrouk, E. Simon, M. Brix, S. Malikov 19 Cd39 is antithrombotic and protects from ischaemia reperfusion injury by adenosine generation. H. Nandurkar, S. Crikis, B. Lu, L. Murray-Segal, C. Selan, S. Robson, P. Cowan, K. Dwyer 19 Dermo epidermal autologous implant device (iddea) produced by tissue engineering R. Vellettaz, M. Lavigne, D. Dominici, L. Correa 20 Use of eco-guided laser approach in the treatment of venous leg ulcers. N. R. Ramírez, N. Lecuona Huet 20 Pushing the limits and optimizing the outcomes of closure fast radio frequency (r-f) ablation and complimentary procedure for gsv-ssv incompetence N. Ibrahim, G. Bicanic, K. Huang, A. Zea, J. Diaz 20 Simultaneous duplex using two probes as a novel method for assessing superficial venous insufficiency C. Lattimer, E. Mendoza VI

9 21 10 years experiences with endovenous laser ablation of varicose veins S. Julinek, I. Maly, D. Klein 21 Incidence of deep venous reflux in primary varicose veins P. Pootracool, S. Jirasiritham, S. Leela-Udomlipi, W. Tirapanich, S. Horsirimanon 22 Early experience with fenestrated and chimney endografts for short neck aortic aneurysms repair in Ramathibodi Hospital. A. Suesawatee, P. Pootracool, S. Horsirimanont, W. Tirapanich, S. Leela-Udomlipi, S. Jirasiritham FREE PAPER SESSION 5 23 Estimation of diagnostic informativity of multispiral computed tomography angiography in patients with peripheral arterial disease by findings of the intraoperative revision. N. Abushov, S. Manafov, N. Hasayeva, E. Zakirjayev 23 Carotid artery stenting via the right brachial access for left carotid stenosis in the bovine arch G. Lianrui, G. Yongquan, T. Zhu, L. Xuefeng, G. Jianming, Z. Jian, W. Zhonggao 24 Interaction of cardio-renal and bone marrow-renal mechanisms and the micro-circulation (capillary) theory of hypertension. J. Myers 24 Retrospective analysis of 200 cases of superficial femoral artery disease D. Dekiwadia, H. Dekiwadia, S. Saji 25 Will the angiosome concept be supported by measurements of microperfusion after tibial angioplasty or bypass surgery? W. Lang 25 Silverhawk plaque excision vs. angioplasty for symptomatic infrapopliteal arterial occlusive disease. J. Guo, Y. Gu, L. Guo, S. Cui, Z. Tong, X. Wu, X. Gao 25 Prevention of groin wound infection after vascular surgery in patients with peripheral arterial disease T. Beck, M. Engelhardt, C. Mueller, C. Willy 26 Nitinol multiple stents in TASC D superficial femoral artery lesions. analysis with ankle brachial index and duplex scan L. Castro, A. Freitas, D. Freitas 26 Inhibiting the superficial femoral artery sympathetic nervous to treat thromboangiitis obliterans T. Jingdong, G. Shujie, Z. Ci, L. Ke, Q. Shuixian 27 Cardiovascular disease prevention in patients with peripheral arterial disease - results of a 5-year observational study A. Blinc, M. Kozak, M. Sabovic, M. Bozic Mijovski, M. Stegnar, P. Poredos, A. Kravos, B. Barbic Zagar, M. Pohar Perme, J. Stare 27 Low flow vascular malformations J. Soracco 27 Open vascular injuries repaired with primary prosthetic graft interposition. Padre Hurtado Hospital s initial 3 year experience. G. Cassorla, C. Hevia, C. Vallejos, J. Torres, H. Rojas FREE PAPER SESSION 6 29 A suggestive activity score for thromboangiitis obliterans B. Fazeli, H. Ravari 29 Ultrasonic wound irrigation experience with chronic wounds over a 24 month period. C. Frank 30 More than one in two instances of venous thromboembolism treated in French hospitals could have occurred during the hospital stay F. Allaert, E. Benzenine, C. Quantin 30 Catheter directed thrombolysis in deep vein thrombosis, technique and results over last decade. D. Dekiwadia 30 Adenosine generation protects in a murine model of antiphospholipid antibody-induced miscarriages H. Nandurkar, A. Samudra, X. Zhang, C. Selan, K. Dwyer, P. Cowan Vol Suppl. 1 to No. 4 VII

10 31 Endovascular treatment of juxtarenal aortic dissections with iliac occlusions using bare metal stents, without proximal stent graft. A. Chatterjee 31 Inferior vena cava filter retrieval, experience of a South American center V. Bianchi, P. Vargas, F. Allamand, G. Cassorla, B. Horwitz 32 Gold Coast Vasculab chronic wound clinic model. C. Frank 32 Social media and the phlebologist s practice. 3 strategies for connecting with patients S. Peek 32 Vnus closure fast radiofrequency ablation. clinical experience of the treatment in patients with lower limb varicose disease. N. Abushov, E. Zakirjayev, M. Karimov, F. Abbasov, Z. Aliyev, G. Abushova 33 The absorption characteristics of the venous wall for the various laser wavelength A. Tsyplyashchuk, Y. Stoyko, K. Mazayshvili, A. Krasnovsky, T. Khlevtova, S. Akimov, M. Yashkin 33 Three parts of the mechanism endovenous laser ablation A. Tsyplyashchuk, K. Mazayshvili, Y. Stoyko, T. Khlevtova, S. Akimov, M. Yashkin OTHER ABSTRACTS 35 Efficacy of rivaroxaban for prevention of venous thromboembolism after knee arthroscopy. a randomized double-blind trial (erika study) G. Camporese, E. Bernardi, F. Noventa, M. Bosco, C. Bortoluzzi, C. Mazzola, G. Zanon, D. Imberti, S. Vitali, C. Lodigiani on behalf of ERIKA. Study Group 35 Fifteen-year follow up of late type i/iii endoleaks after evar. how safe is non-interventional treatment J. May 36 Treatment of the venous thoracic outlet syndrome (pagetschroetter) E. Molina 36 Arterial complications of cervical ribs. Surgical outcome S. A. Nurul Alam, 37 Popliteal vein compression D. Huber 37 Venous thromboembolism in asia an unrecognised and under-treated problem? P. Angchaisuksiri 37 Coronary microcirculation in diabetic and hypertensive patients S. Novo, V. Sucato, A. Quagliana, S. Evola, E. Bronte, G. Inga, G. Pace, G. Tona, R. Trovato, G. Novo 39 Polarisation of the monocyte classical subset to an m1 phenotype in atherosclerosis H. Medbury, H. Williams, G. Cassorla, N. Pertsoulis, N. Marmash, V. Patel, K. Hitos, J. Fletcher 39 Blood vessel regenerative medicine in China Y. Gu, J. Zhang, Z. Wang 40 Intimal hyperplasia development and characterization in a nitinol u-clip versus sutured arteriovenous anastomosis R. Varcoe 40 Catheter directed thrombolysis for deep vein thrombosis. preliminary results from Chile V. Bianchi, P. Vargas, G. Cassorla, B. Horwitz, F. Allamand 40 Closurefast endovenous radiofrequency ablation (ERFA) for GSV-SSV incompetence: efficacy and failure patterns. a 3-year follow-up N. Ibrahim, K. Huang, A. Zea, J. Diaz, G. Bicanic 41 Dyslipidemia in peripheral artery disease with respect to presence/absence of smoking and diabetes mellitus. J. Pitha, D. Karetova, B. Seifert, J. Vojtiskova, K. Roztocil 41 Endovenous heat-induced thrombosis (EHIT) after EVLT of GSV with 1470nm laser and bared tip fibers R. Vellettaz 42 Pelvic congestion syndrome C. Jara, A. Kornberg, J. Pratt 42 Diagnostic guidelines of vascular anomalies. vascular malformations and hemangiomas P. Antignani 43 Outcomes following elective non-fenestrated aaa repair. 13 years experience M. Neale, M. McCaffrey, J. Edwards, C. Thoo VIII

11 43 Pedal bypass with deep venous arterialisation for the limb salvage in critical limb ischemia with unreconstructable distal artery P. Mutirangura, C. Ruangsetakit, C. Wongwanit, N. Sermsathanasawadi, K. Chinsakchai 44 Combining drug-eluting stents and stent-grafts for the treatment of femoro-popliteal occlusive disease. early outcomes R. Huilgol, D. Hagley 44 Genetics in primary lymphoedema S. Michelini, A. Bruson, M. Cardone, F. Sirocco, A. Fiorentino, S. Cecchin, F. Cappellino, M. Bertelli 44 Anatomy and Micro-anatomy of the lymphatic system N.B. Piller 45 Postoperative control of type ii endoleaks in patients submitted to evar for aaa B. Gossetti 45 The role of duplex ultrasound in the management of peripheral artery disease R. Pulli 46 Metabolic syndrome and cardiovascular risk S. Novo, V. Evola, M. Sinacori, A. Peritore, R. Trovato, F. Guarneri, E. Corrado, I. Muratori, G. Novo 47 Private community screening for vascular disease in Australia S. Kitchener, R. Denniss 47 Contemporary diagnostic evaluation - update N.B. Piller 48 Clinical applications of novel angiographic scoring system M. Jackson, C. Krampl 48 Is aspirin still the drug of choice for management of peripheral arterial disease? P. Poredoš 49 Anticoagulant drugs for the management of peripheral arterial disease (pad) M. Jezovnik 49 Objective proof for oedema reduction N.B. Piller 50 Four-layer compression is an effective treatment for lower limb venous ulceration A. Giannoukas, N. Rousas, M. Papadopouloy, A. Drakoy, R. Stankova-Salta, C. Nakos, V. Salepstis, K. Spanos, A. Athanasoulas, 50 Factors associated with short-term endoleak development after EVAR with the use of new generation endografts A. Giannoukas, V. Saleptsis, K. Spanos, K. Antonopoulos, C. Karkos, C. Ioannou, D. Tsetis, I. Kakissis, K. Papazoglou, C. Liapis, 51 Experience with endovascular repair of complex abdominal aortic aneurysm Y. Gu, L. Guo, L. Qi, H. Yu, X. Li, B Chen, Z. Tong, X. Wu, J. Guo, Z. Wang 51 Prospective randomized trial of endovenous laser ablation of great saphenous veins with 1470 nm diode laser and 2ring fibers comparing compression therapy 0 days, 7 days and 28 days after therapy. U. Maurins, J. Rits, A. Kadiss, S. Prave, E. Rabe, F. Pannier 52 Prevalence of venous thromboembolism treated in French and USA hospitals F. Allaert, E. Benzenine, C. Quantin 52 New trends for pathophysiology and diagnosis in critical limb ischemia P. Antignani 52 New trends in medical treatment in critical limb ischemia. current state and future directions P. Poredoš 53 Preliminary results from a screening programme of lower limb arterial occlusive disease in elderly males in central greece A. Giannoukas, N. Rousas, G. Makrygiannis, V. Saleptsis, K. Spanos, C. Argyriou, S. Koutsias, 53 Thrombophilia panel results in patients after the first venous thromboembolic event in view of recommended selection criteria for thrombophilia testing J. Hirmerova, J. Seidlerova, I. Subrt, J. Slechtova Vol Suppl. 1 to No. 4 IX

12 54 New approach in the treatment of heparin-induced thrombocytopenia B. Chong, Z. Ahmedi, J. New, X. Jiang 54 Combining drug-eluting stents and stent-grafts for the treatment of femoro-popliteal occlusive disease: early outcomes R. Huilgol, D. Hagley 54 Management of acute and chronic pain R. Halliwell ELECTRONIC POSTERS 57 Low concentration detergent sclerosants stimulate white blood cells apoptosis in vitro O. CooleyAndrade, W. XianGoh, D. Connor, K. Parsi 57 Ex-vivo and in vitro analysis of coagulum formation after administration of detergent sclerosants D Connor, O. CooleyAndrade, J. Weisel, K. Parsi 57 The effect of temperature on sclerosant foam stability and structure X. Tan, G.C. Valenzuela, K. Wong, D. Connor, M. Behnia, K. Parsi 58 The effect of dilution with water or saline on the critical micelle concentration of detergent sclerosants K. Wong, T. Chen, D. Connor, M. Behnia, K. Parsi, 58 High incidence of haemostatic defects in pigmented purpuric dermatoses D. Vekic, D. Connor, K. Parsi 59 Sclerosant foam structure is strongly influenced by the liquid air fraction E. Cameron, T. Chen, D. Connor, M. Behnia, K. Parsi 59 Sonographic anatomy of t he sural nerve in relationship to endovenous thermal ablation of incompetent small saphenous vein N. Ibrahim, K. Huang, A. Zea, J. Diaz 59 Classification and algorithmic selective management of ssv incompetence (reflux) in radiofrequency endovenous ablation (evrfa) setting N. Ibrahim, A. Zea, K. Huang, J. Diaz 60 Hydrodisplacement to safeguard sural nerve and to optimise closurefast endovenous thermal ablation (EVTA) of small saphenous vein (SSV) incompetence. N. Ibrahim, A. Zea, K. Huang, J. Diaz 60 Intra-arterial injections of sclerosants: management with steroids P. Hannaford, K. Parsi 61 Therapeutic strategy of intravenous leiomyomatosis with intracaval and intracardiac extension in 18 cases L. Guo 61 Treatment of chronic venous insufficiency with superficial, perforator, and deep vein surgery. Y. Hoshino 61 Ultrasound guided foam sclerotherapy (UGFS) to treat varicose veins at the WA Vascular Centre J Teasdale 62 Telemedicine screening for vascular disease of lower limbs M. Petrlik, T. Bohrn 62 Limiting indications for varicose vein surgery to maximise service provision in an era of restricted funding; an audit of compliance at the GCHHS M. Bavahuna, M. Jackson, W. Butcher 63 Treatment of scrotal and pelvic varicocele: our experience. R. Moia, A. LaRosa, J Clerissi, C. MassaSaluzzo, E Moia, V. Saracino, E. Castronovo, R. Nuzzo, M. Dondi 63 Recurrent varicose veins post CHIVA R. Moia, A. LaRosa, J Clerissi, C. MassaSaluzzo, E Moia, R. Nuzzo, V. Saracino, M. Dondi, E. Castronovo 63 Endovenous laser ablation in symptomatic patients with varicose veins: saphenous vein diameter and reflux detection correlates well with clinical symptoms. M Vítovec, V. Horvath, M. Slais, J. Honek, T. Honek 64 Clinical outcome of patients with truncal saphenous incompetence: comparison of endovenous laser ablation and conservative treatment. M Vítovec, J. Honek, M. Slais, V. Horvath, T. Honek X

13 64 Heredity of chronic venous disorders: an epidemiological study on patients challenging the predominantly maternal character of CVD heredity F. Allaert, V. Crebassa, J. Guex 65 Development and validation of the psychometric properties of a self-reported questionnaire assessing adherence to the wearing of elastic compression stockings F. Allaert, D. Rastel, A. Graissaguel, B. Lun, G. Chauferind 65 Causes of recurrent varicose veins D. Musil, J. Herman, M. Tichy, P. Bachleda 66 Axial splitting of medial cutaneous nerve of forearm facilitates the 2nd stage superficialization of basilic or brachial vein in patients with brachial basilic or brachial brachial arterio-venous fistula. S. Przywara, T. Zubilewicz, M. Ilzecki, P. Terlecki 66 Risk factors for failure of native arteriovenous fistulas (kafka study) M. Harazim, I Hofírek, O. Sochor 66 Isolated acute abdominal aortic dissection with huge pseudoaneurysm successfully treated with combination of bare metal stent and unibody bifurcated stent graft B Yang 67 AAA morphology and management: what features effect treatment and outcome by evar T Daly, J Mah, N Young, K Hitos, J Fletcher 67 Differential diagnosis of aortic dilatation in pictures M Kaletova, D Musil, P Marcian, J Ostransky, M Cerna, M Taborsky 68 Endovascular interventional treatment of superior mesenteric arteries stenosis L. Tan, S. Sheng-Han, Z. Wang-De, Z. Yang, Y. Biao, Y. Bao- Zhong 68 Pseudo aneurysms: endovascular treatment R. Moia, A. LaRosa, J Clerissi, C. MassaSaluzzo, E Moia, M. Dondi, R. Nuzzo, V. Saracino, E. Castronovo 68 Endovascular treatment of peripheral aneurysms R. Moia, A. LaRosa, J Clerissi, C. MassaSaluzzo, E Moia, R. Nuzzo, V. Saracino, E. Castronovo, M. Dondi 69 Aneurysms of visceral arteries: endovascular treatment R. Moia, A. LaRosa, J Clerissi, C. MassaSaluzzo, E Moia, M. Dondi, R. Nuzzo, E. Castronovo, V. Saracino 69 Prevention and treatment of conversion complications in totally laparoscopic aortic bypass surgery for aortoiliac occlusive disease G. Lianrui, G. Yongquan, Q. Lixing 70 Management strategy of isolated spontaneous dissection of the superior mesenteric artery H Satokawa, H Yokoyama, T Igari 70 Open surgical repair for inflammatory abdominal aortic aneurysms K Igari, T Kudo, M Nakamura, S Katsui, M Nishizawa, H Uchiyama, S Koizumi, T Toyofuku, Y Inoue 70 Replantation of amputated arms M Salah 71 Angiographic findings of patients with extremity injuries: is vascular proximity it a valid indication for angiography? H. Ravari, A. Bahadori, M. PezeshkiRad, O. Ajami 71 Iatrogenic injury to the superior vena cava and brachiocephalic vein J. Herman, D. Musil, P. Bachleda, M. Cerna, V. Prasil, P. Santavy 72 Endovascular treatment of arterio-venus malformations R. Moia, A. LaRosa, J Clerissi, C. MassaSaluzzo, E Moa, E. Castronovo, V. Saracino, M. Dondi, R. Nuzzo 72 SEVERE LYMPHEDEMA OF THE LOWER LIMBS. TRANSDISCIPLINARY TREATMENT J. Soracco, J L. Ciucci, J. Krapp, O. Regalado, L. Marcovecchio, S. Gerez, M. Amore, G. Bengoa, F. Díaz Bessone, L. Rodríguez 72 Variation of blood vessels in the cranial-cervical region. rare forensic pathological findings due to variation of the blood vessels S Furukawa, S Morita, H Okunaga, L Wingenfeld, K Nishi 73 Efficacy and safety of 12 to 24 versus 25 to 36 months of dual antiplatelet therapy after implantation of overlapping drug-eluting stents D Kim, J Kim, B Hwang, K Yoo, S Her, K Moon Vol Suppl. 1 to No. 4 XI

14 73 Clinical efficacy of endovascular therapy in critical limb ischemia of the upper limb T. Sahu 73 Porphyromonas gingivalis and platelets aggregation in patients with peripheral artery disease. M. Jibiki, Y. Inoue 74 Bone marrow derived stem cell therapy to stimulate angiogenesis in patients with critical limb ischaemia A. Morrow, M. Krishnaswamy, J. Griffin, D. McClure 74 Pre-reconstruction of cervical-to-petrous internal carotid artery: improved technique for treatment of vascular lesions involving internal carotid artery at the skull base F. Li, Y. Zheng 75 Load transfer from the foot to the walls of the total contact cast in patients with a diabetic foot wound. L. Begg, P. McLaughlin, M. Vicaretti, J. Fletcher, J. Burns 75 Efficacy of short-term catheter-directed thrombolysis used with rt-pa combined with endovascular interventional therapy in patients with lower limb ischemia Z. Yang, Z. Wangde, L. Tan, Y. Biao, S. Shenghan. 76 The influence of ozonated autohemotherapy on lipid peroxidation system in patients with thromboangiitis obliterans and critical limb ischemia. N. Abushov, E. Zakirjayev, R. Guliyev, M. Ahmadov, G. Tagizade, E. Aliyev, L. Mammadova 76 Establishment of the Brunei diabetic foot registry N. HajiZaine, K. Hitos, J. Fletcher, M. Vicaretti, L. Begg, J. Burns 76 Endovascular treatment of iliac arteries R. Moia, A. LaRosa, J Clerissi, C. MassaSaluzzo, E Moia, E. Casronovo, V. Saracino, R. Nuzzo, M. Dondi 77 Endovascular treatment in patients with below the knee vessels desease R. Moia, A. LaRosa, J Clerissi, C. MassaSaluzzo, E Moia, E. Castronovo, V. Saracino, M. Dondi, R. Nuzzo 77 Endovascular rivascularization of the lower limb through profunda femoral artery R. Moia, A. LaRosa, J Clerissi, C. MassaSaluzzo, E Moia, R. Nuzzo, M. Dondi, E. Castronovo, V. Saracino 78 Efficacy and safety of hybrid therapy for complex peripheral arterial disease S. Ito, M. Hashimoto, N. Katayama, T. AMemiya, H. Suesada, H. Tsuchida 78 Microcirculation in patients with clinical signs of critical lower limb ischemia S. Rosfors, L. Kanni, T. Nystrom 78 Dying digits, no place to run no place to hide D Dekiwadia 79 N-3 polyunsaturated fatty acids, 24-h ambulatory blood pressure, and heart rate in incident hypertension J. HagstrupChristensen, C. Strandhave, M. Svensson, E. BergSchmidt 79 The Impact of Plain X-ray Calcium Score in Revascularized Critical Limb Ischemia Patient B. Wasin, H. Suthas, P. Piyanut, T. Wiwat, L. Surasak-Udomlipi, J. Sopon 80 Long-term Patency and Fracture Rates of Stents Placed in the Popliteal Arteries in Chinese Patients With Chronic Critical Limb Ischemia or Lifestyle-limiting Claudication C. Shijun, G. Lianrui, L. Xuefeng, W. Xin, T. Zhu, Z. Jian, G. Yongquan 80 Tibial angioplasty for limb salvage in patients with endstage renal disease (esrd) W. Lang, A. Meyer 81 Effect of low-level laser therapy on blood flow and oxygenhemoglobin saturation of the foot skin in healthy subjects W. Lang, F. Heu, B. Namer, C. Forster 81 Endovascular mechanical rotational thrombectomy in cases of occluded native arteries, bypass grafts and stents T. Zahariev, V. Govedarski, S. Genadiev, I. Petrov., B. Denchev, G. Nachev 81 Fibulin-1 levels in patients with coronary artery disease H. Karpuz, D. Filiz, B. Ikitimur 82 Reduced thickness of the choroid in patients with asymptomatic internal carotid artery stenosis. pilot study. S. Przywara, A. Zubilewicz, P. Bielinski, M. Ilzecki, P. Terlecki, J. Mackiewicz, T. Zubilewicz XII

15 82 Application of micronized diosmin in patients with chronic peripheral artery disease of the lower limbs T. Zahariev, S. Dimitrov, V. Popov, B. Denchev, G. Nachev 83 Nitinol multiple stents in TASC D superficial femoral artery lesions: analysis with ankle brachial index and duplex scan L. Castro, A. Freitas, D. Freitas, C. Virgini, P. Areas 83 Above knee femoropopliteal TASC C and D revascularization angioplasty with single or multiple stents versus bypass surgery L. Castro, A. Freitas, C. Virgini, D. Freitas, P. Areas 83 Prevalence of venous thromboembolism in hospitalized patients with haematological malignancies receiving chemotherapy A. Wiszniewski, P. Szopinski, K. Warzocha 84 An uncommon case of deep venous thrombosis and pulmonary thromboembolism in a juvenile with compound heterozygous congenital protein S deficiency I. Kosugi, S. Matano, F. Taniguchi, E. Morishita 84 Role of pharmaco-mechanical thrombolysis in acute deep vein thrombosis. V. Chadachan, N. Pandit, M. Singh, J. Tay 85 VTE events in patients with advanced metastatic bladder cancer treated with cisplatin and gemcitabine P. Patrik, K. Dostálová, V. Štvrtinová, G. Annaáková 85 Pulmonary tuberculosis associated venous thromboembolism: how to diagnose and treat V. Chadachan, N. Pandit, J. Tay 86 Compliance of arthroplasty surgeon protocols with Australian guidelines for preventing VTE JM Naylor, Badge H, Harris IA, Fletcher J, Xuan W,Armstrong E,, Lin C. 86 Venous Thromboembolism Prophylaxis in Surgery J Butterworth 87 Evaluation of postthrombotic syndrome in patients treated by catheter directed thrombolysis for deep vein thrombosis (3 years follow up) D Karetova, D Rucka, J Lubanda, L Skalicka, S Heller, M Chochola, P Prochazka, P Varejka, A Linhart 87 Midterm outcome of endovascular treatment for acute lower extremity deep venous thrombosis X Li, Q Meng, K Jiang, H Sang, J Rong, X Yu, A Qian 88 Cost-effectiveness of pharmacological prophylaxis in preventing venous thromboembolism and associated long term complications in colorectal surgery K. Hitos, B. Sanderson, C. Stratton, J. Fletcher 88 Epidemiology of venous thromboembolism after major trauma: the efficacy, cost-effectiveness and associated bleeding complications with pharmacological prophylaxis K. Hitos, J. Hsu, C. Stratton, J. Fletcher 89 Exercise training suppresses strenuous exercise-induced procoagulant factors and thrombin generation Y. Chen, J. Wang 89 Stop the clot L Everest-Rolfe, U Buehner 90 Surgical thrombectomy and simultaneous stenting for deep venous thrombosis caused by May-Thurner syndrome M. Nishizawa, T. Kudo, K. Igari, M. Nakamura, S. Katsui, H. Uchiyama, S. Koizumi, T. Toyofuku, Y. Inoue 90 Air travellers: a pharmacist s study shows a higher risk of DVT than usually described and the benefit of wearing elastic compression F. Allaert, J. Mongold 91 How do we safely anticoagulate a patient with pulmonary embolism who is having recurrent haemoptysis in an outpatient setting? A. Sule, S. Gohar, J. Tay 91 Left iliac vein thrombosis in a young patient: need to evaluate for May Thurner syndrome? T. Quah, A. Sule, J. Tay 92 Progression of thrombus in portal vein, superior mesenteric vein and splenic vein even on anticoagulation in a patient with ascending colonic malignancy with liver metastasis portal vein thrombosis vs portal vein tumour thrombosis A. Sule, A. Borja, J. Tay 92 Treatment of pulmonary embolism with hemoptysis in a middle aged lady on low molecular weight heparin in outpatient setting and role of peak anti- xa monitoring C. Yee, A. Sule, S. Gohar Vol Suppl. 1 to No. 4 XIII

16 93 Popliteal vein aneurysm: a rare cause of pulmonary embolism R Flekser, W Mohabbat 93 Vascular imaging and renovascular disease L Aluigi 94 T1, and t2 weighted se carotid plaque imaging and contrastenhanced mr angiography comparison with intravascular ultrasonography (qualitative and quantitative assessment) - pilot study W Iwanowski 94 Diagnosis of acute thrombosis using non-invasive molecular ultrasound imaging and novel platelet-targeted microbubbles. X Wang, C Hagemeyer, J Hohmann, I Ahrens, K Peter 95 Evaluation of intracranial haemodynamic by TCCS in patient with significant asymptomatic internal carotid stenosis case report J. Zizka 95 Evaluation of intracranial circulation in selection of patients with asymptomatic carotid stenosis to carotid endarterectomy role of transcranial ultrasound J Zizka XIV

17 FREE PAPER SESSION 1 Evaluating the intracranial perforating branches by micro angiographic system using a rotating cerium anode C. Tanaka, Y. Ikeya, T. Shizuma, N. Fukuyama, H. Mori Kanagawa, Japan Purpose. The clinical availability of X-ray radiographic system using a rotating cerium anode which we developed is discussed. We evaluated the resolution for the perforating branches from the middle cerebral artery which may cause cause lacunar infarction. Methods and Materials. The new micro angiographic system was developed with a cerium anode which has characteristic X-ray around 34.6Kev. It is close to K-edge of contrast materials (Iodine and Barium), therefore, the system can detect tiny amount of the materials. Additionally, the high X-ray photon flux generated by 5MHU generator allows to maintain enough photon number at the surface of a flat panel detector even after passing through the body. Three animal experiments were performed. First, barium was injected from the left ventricle during the heart beating to spread intracranial vessels in 32 rats. Second, barium was injected from the ascending aorta during the heart beating in 3 dogs. Then the brains of rats and dogs were removed and irradiated. Third, in living 2 dogs, iodine was injected into the ascending aorta under radiation by the new angiographic system to visualize the movement of materials in the perforating branches. Results. The new angiographic system showed the circle of Willis and the perforating branches in the rats. In the brains of dogs, it showed those arteries more clearly. The minimum diameter of vessels which were visualized was approximately 50μm. In the living dogs, it visualized the realtime movement of materials inside of the perforating branches which are difficult to be evaluated by the conventional methods. Conclusion. The system visualized the perforating branches, and the resolution was preserved even in the living body. It can be used in clinical settings, and will help in evaluating the intracranial small vessels, decreasing invasive examinations, and elucidating the functions or pathologies which are unknown. An endovascular-first paradigm shift results in superior limb salvage rates S. Thomas, N. Katib, R. Varcoe University of New South Wales, Sydney, Australia Adopting an Endovascular-first strategy (endofirst) to treat critical limb ischaemia (CLI) is contentious, with evolving technique and technological improvements vexing the applicability of literature reported results. In this study, we analysed long term limb salvage outcomes produced by an overall shift in strategy 4 years ago from an open first to a contemporary and aggressive endo first strategy. With a change in strategy occurring in July 2008, we collected longitudinal admission and interventional data for all patients presenting with CLI to our institution between January 2004 and June Patients were allocated to a therapeutic group (Non-revascularisation, Endo-first, Open First) based on the initial revascularisation procedure. The primary outcome measure was defined as freedom from amputation, with secondary outcomes of minor amputation rate, Vol Suppl. 1 to No. 4 INTERNATIONAL ANGIOLOGY 1

18 length of hospital stay, admissions/patient and Intensive care Utilisation time. 307 patients with 357 critically ischaemic limbs were recorded, with 86 Patients (96 Limbs), 68 patients (74 limbs) and 153 patients (187 Limbs) allocated to the Non-revascularsation, Open first and Endo first groups respectively. There were fewer limbs with Ulcers/gangrene in Open-first group (55.4%) compared to the Non-revascularisation (91.7%) and Endo-first (79.7%) group (p<0.001). There were less major amputations in the Endofirst group (n=8, 4.3%) compared to the Openfirst (n=17, 23%) and Non-revascularisation group (n=23, 24%: p<0.001). Kaplan-Meier estimates demonstrated persistent freedom from amputation in the endo-first group compared to the other two groups out to 8 years (p<.05). Whilst there was a trend towards more admissions/patient and minor amputation/debridements in the endo-first group compared to the other two groups, there was a decreased length of stay and ICU utilisation time in the endo-first group. An endo first approach is associated with a trend towards a higher minor amputation rate and readmission rate, however major amputation is significantly reduced, with a persistent benefit out to 8 years. Covered stents in treating peripheral aneurysms in patients with behcet s disease Z. Sun, H. Wang, Y. Shen, W. Jiang Heilongjiang, China Behcet s disease (BD) is a chronic multisystemic disorder of unknown etiology that is prevalent in the Middle East, the Mediterranean, and East Asia. Vascular involvement is not uncommon in BD. Peripheral aneurysms (PAs) in BD are not rare. Complications of PA such as thrombosis, embolism and rupture might threaten organs, limbs and even the patient s life. In the past two decades, endovascular repair has emerged as a safe and efficient treatment method and a possible surrogate of open surgery for aneurysms caused by BD. Aneurysms caused by BD are subject to high recurrence and complication rates which usually require reintervention. Up to date, systemic comparison between endovascular and open surgical methods is lacking. Since July 2007, 11 peripheral aneurysm cases (male 9, mean age 45.2y) were treated in our unit, and 3 patients were suffering from BD and managed with covered stents. There was 100% overall technical success, 100% primary patency and 0% of overall peri-op mortality for both BD and non- BD patients. Perioperative complications included 2 cases (18%) of gastrointestinal bleeding, 1 case (9%) of distal thrombosis. A mean follow-up of 24.5 months revealed one death (9 %) due to heart failure 4 years after aneurysm repair; patency rate was 90% (10/11) with one restenosis in a BD patient and need reintervention. Compared with non-bd patients, BD patients tend to relapse in aneurysm or thrombosis in stents. Relevant literature has shown comparable outcomes of endovascular treatment for vasculo-behcet s disease in contrast to open surgical repairs. In conclusion, aneurysms developed in Behcet s disease, though subject to clinical treatment difficulties, could be effectively and safely managed through endovascular techniques such as covered stents. In the future, however, large series data are needed to determine the long-term patency and reintervention rate Covered stent for carotid aneurysm in patients with bovine aortic arch A. Bashar, G. Hossain, E. Hakim, N. Mandal, M. Hossain, N. Dey, S. Alam National Institute of Cardiovascular Diseases & Hospital, Bangladesh Introduction. Carotid aneurysm constitutes less than 1% of all carotid pathologies and less than 4% of all peripheral aneurysms. Treatment options include open surgical repair and endovascular exclusion. Surgical repair- an extensive procedure entails significant morbidity and mortality risks. Endovascular exclusion is emerging as an effective alternative treatment. We undertook this study to analyze our initial experiences with the endovascular exclusion of carotid aneurysm with covered stent. Methods. Over a period of 2 years, five male patients aged between years presented with pulsatile neck swelling. Duplex ultrasound established the diagnosis of aneurysm of left common carotid artery (LCCA) in 3 cases, left internal carotid artery (LICA) in 1 and right common carotid artery (RCCA) in 1. Arch aortogram revealed bovine type aortic arch in 2 patients- both having aneurysms in the left carotid system. In one of these patients, the LCCA took origin from the Brachio- Cephalic Trunk (BCT) and in another LCCA and BCT had a common origin from the arch. Wire manipulation from the BCT into the left carotid system was significantly difficult in cases with bovine arch. Long sheath supported hydrophilic terumo guide wire was helpful. Covered stents used to exclude the aneurysms were of self-expanding type in 2 patients and balloon expandable type in 3. No cerebral protection device (CPD) was used. Results. Successful aneurysm exclusion was 2 INTERNATIONAL ANGIOLOGY August 2014

19 Vascular complications in intravenous drug abusers. vascular surgeons up against a social scourge in a developing country A. Bashar, G. Hossain 1, E. Hakim 1, M. Hossain 1, N. Mandal 1, S. Alam 1 1National Institute of Cardiovascular Diseases & Hospital, Dhaka, Bangladesh Objectives. Intravenous drug abuse (IVDA) is a global health care problem that has tremendous socio-economic implications. Vascular complicaachieved in all five cases. In 2 patients receiving self-expanding device, small proximal type I endoleak was seen which persisted even after additional balloon angioplasty. No neurological deficit was noted. Conclusion. Endovascular intervention with covered stents is a safe, effective and minimally invasive option to treat carotid aneurysms even when performed without CPD. Aneurysm in the left carotid system in patients with bovine arch may present significant technical difficulty. Balloonexpandable devices were likely to have more precise placement. Has carotid artery stenting found its place? a 10-year regional centre perspective. N. Biggs, S. Rangarajan, D. McClure Geelong, Victoria, Australia Introduction. The post Carotid Revascularization Endarterectomy versus Stenting Trial era has seen a dramatic decline in the practice of carotid artery stenting (CAS). A retrospective review of prospectively collected CAS outcomes over a 10-year period by a single operator was undertaken to determine if this change in practice is justified, and to identify the place of carotid stenting in current practice. Methods. One hundred and fifty nine carotid stent procedures were undertaken on 137 patients from 2002 to Cases were selected for CAS only if they fulfilled the inclusion criteria for the SAPPHIRE trial. Post-procedural outcomes were compared against those of a contemporaneous cohort of patients undergoing endarterectomy (CEA) by the same operator, and against published metaanalyses. The measure of CAS durability was need for reintervention, based on the presence of ultrasound detected restenosis > 70%. Results. No significant difference was identified in 30-day complication rates between patients undergoing CAS and those having CEA. Compared to published meta-analyses of CAS, our practice was accompanied by a significantly lower rate of periprocedural stroke (1.26% vs. 6%, p=0.014), while carrying equivalent 30-day death and myocardial infarction. Four stented arteries had reintervention, due to asymptomatic in-stent stenosis of >70%. Further intervention was declined in a fifth case. This represents a restenosis rate of 3.1% over a mean follow up of 40.2 ± 27.6 months. Discussion. Carotid artery stenting can provide a safe and durable treatment option for selected patients with carotid artery disease, in the hands of appropriately trained proceduralists who meet accepted standards of practice. Contemporary epidemiological study of abdominal aortic aneurysm (aaa) in men and women of different ages. a case-control study M. Chabok, M. Farahmandfar 1, M. Aslam 2, N. Garbani 3, A. Manganaro 3, J. Coltart, A. Nicolaides 2 1Imperial College London, Life Line Screening 2Imperial College London 3Life Line Screening London, UK Introduction. Most recent population screening studies for AAA focused on men 65 y/o and provided little information on women and/or younger patients. Whilst AAA in women is less frequent than in men, women are reported to have a poorer outcome compared with men. Specific risk factors are associated with the development of AAA, and subgroups of women can be identified that are at a substantially increased risk of aneurysmal disease. We aim to identify factors that are independently associated with AAA. Methods. Demographics and risk factors were collected from 2069 patients with AAA, including women and <65 years old subjects, detected by ultrasound screening. For statistical analysis, 2069 age and gender matched cases were randomly selected from the same database. Logistic regression was used to look at factors associated with having AAA including age, gender, diabetes, cardiovascular disease (CVD), hypertension, hyperlipidaemia, exercise, smoking, BMI, family history of CVD and AAA. Results. There were 444 women (21.4%) and 1625 (78.6%) with AAA in this cohort. The mean age for both cases and controls was 71.4 (±7.5) years with identical sex distribution. For women, there was no evidence of an association between smoking, hypertension, family history of AAA and atrial fibrillation. For men, significant carotid artery disease, history of MI, diabetes, hyperlipidaemia, smoking, family history of AAA and stroke were determined to be independent risk factors for AAA. Vol Suppl. 1 to No. 4 INTERNATIONAL ANGIOLOGY 3

20 tions following IVDA are not uncommon and may have serious consequences. At the National Institute of Cardiovascular Diseases (NICVD), Dhaka, Bangladesh, there has been a steady rise in the number of cases with vascular complications of IVDA in recent years. The aim of the study was to analyze our experiences with various types of vascular complications following IVDA. Materials and Methods. Between January 2011 and December 2013, a total of 135 patients presented with various complications of IVDA. One hundred and seven patients presented with bleeding from ruptured pseudoaneurysm or impending pseudoaneurysm rupture and the remaining 28 with Deep Venous Thrombosis (n=13), superficial thrombophlebitis (n=12) and acute limb Ischemia due to thromboembolism (n=3). For the management of pseudoaneurysm, resuscitation was done when necessary followed by excision of pseudoaneurysm either with simple ligation of the artery (Group A, n=77) or with restoration of arterial continuity (Group B, n=30), decision being guided mainly by the severity of infection. Outcome in the two groups were compared against the following parameters; acute limb ischemia, chronic limb ischemia, wound infection and lymphorrhoea. Results. There was no in-hospital mortality in this series. Both ligation and restoration of arterial continuity following aneurysmectomy were effective in treating the bleeding aneurysm. However, restoration of arterial continuity was more effective in preventing acute and chronic limb ischemia than simple ligation. (P=0.04 and 0.02, respectively). Most patients required long-term general and plastic surgical care. Conclusions. In Bangladesh, the incidence of IVDA with vascular complications is increasing at an alarming rate. Management of these patients requires dedicated centers with vascular surgical expertise and appropriate logistic support. Restoration of arterial continuity should be targeted whenever feasible to prevent acute and chronic limb ischemia in these patients. Hemolytic anemia in thromboangiitis obliterans; a report of 29 cases B. Fazeli, H. Ravari, M. Akbarin Khorasan, Iran Introduction. The aetiology and pathophysiology of Thromboangiitis Obliterans (TAO) remains puzzling. Plasma samples from many TAO patients show evidence of anaemia and macroscopic haemolysis, which may indicate haemolytic anaemia. Potential causes causes were investigated. Methods. An Indirect Coombs test, and tests for lactate dehydrogenize (LDH), D-aspartate aminotransferase (AST), D-alanine aminotransferase (ALT), and complements system proteins C3 and C4 were evaluated in 29 plasma samples, which had been banked between 2010 and 2012 from patients diagnosed with TAO. Results. The indirect Coombs test was positive in 23 out of 29 samples (79.2%). The mean documented haemoglobin of the patients was 12.28±0.6 g/dl. The LDH level was high in all samples, with a mean of 2552±315 u/l. High levels of AST (mean: 67±7 u/l), normal levels of ALT (26±3 u/l), high levels of C3 (2.08±0.7g/l) and normal levels of C4 (0.38±0.11g/l) were also observed. Conclusion. These results indicate that many TAO patients have haemolytic anaemia. However, in light of the clinical manifestation of TAO and the relatively high levels of C3 and C4 in the samples studied, haemolytic anaemia in TAO is likely to be due to the presence of infectious pathogens rather than autoimmune mechanisms. Investigation of disease severity in patients with scleroderma using the lakk-m device F. Adams, J. Millar 1, S. Sokolovski 2, J. Belch 1, E. Rafailov 3, F. Khan 1 1Vascular & Inflammatory Diseases Research Unit, Ninewells Hospital & Medical School, Dundee, Scotland 2Photonics & Nanoscience Group, Division of Physics, University of Dundee, Dundee, Scotland 3Aston Institute of Photonic Technologies, Aston Triangle, Birmingham, England Scleroderma is a chronic autoimmune disorder characterised by collagen deposition in the skin. The skin may be used as a marker of disease activity and progression; however currently there are no objective tests available. The multifunctional laser-based non-invasive diagnostics system (LAKK-M) has been developed as part of the MEDILASE project (Multifunctional Medical Diagnostic LASEr) to simultaneously monitor several tissue parameters (microcirculation & oxygen levels; fluorescence of endogenous tissue biomarkers: collagen, flavins etc.) and may provide a useful method to detect varying degrees of scleroderma. The aim of this study was to use the LAKK-M to investigate the extent of disease severity in patients with scleroderma using skin autofluorescence and to compare these results with healthy subjects free of cardiovascular disease (CVD). The LAKK-M was used to measure skin fluorescent biomarkers related to vascular function and 4 INTERNATIONAL ANGIOLOGY August 2014

PRESIDENTS of the Congress Claudio Allegra (Italy) Pier Luigi Antignani (Italy)

PRESIDENTS of the Congress Claudio Allegra (Italy) Pier Luigi Antignani (Italy) PRESIDENTS of the Congress Claudio Allegra (Italy) Pier Luigi Antignani (Italy) Organizing Scientific Committee: Executive Committee of Italian Society for Vascular Investigation L. Aluigi T. Baroncelli

More information

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty Round Table: Antithrombotic therapy beyond ACS Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty M. Matsagkas, MD, PhD, EBSQ-Vasc Associate Professor

More information

Surgical Options for Venous Disease. Sandra C Carr MD Vascular Surgery Meriter Wisconsin Heart

Surgical Options for Venous Disease. Sandra C Carr MD Vascular Surgery Meriter Wisconsin Heart Surgical Options for Venous Disease Sandra C Carr MD Vascular Surgery Meriter Wisconsin Heart Chronic Venous Disease Approximately 23% of adults in the US have varicose veins Estimated 22 million women

More information

EFSUMB EUROPEAN FEDERATION OF SOCIETIES FOR ULTRASOUND IN MEDICINE AND BIOLOGY Building a European Ultrasound Community

EFSUMB EUROPEAN FEDERATION OF SOCIETIES FOR ULTRASOUND IN MEDICINE AND BIOLOGY Building a European Ultrasound Community MINIMUM TRAINING REQUIREMENTS FOR THE PRACTICE OF MEDICAL ULTRASOUND IN EUROPE Appendix 8: Vascular Ultrasound Level 1 Training and Practice Practical training should involve at least two half day ultrasound

More information

Thrombolysis, thromboaspiration, ultrasound thrombectomy: adjuncts techniques for aorto-iliac recanalization.

Thrombolysis, thromboaspiration, ultrasound thrombectomy: adjuncts techniques for aorto-iliac recanalization. Thrombolysis, thromboaspiration, ultrasound thrombectomy: adjuncts techniques for aorto-iliac recanalization. Dr. S. Schepers Dr. F. Van Elst Sint-Trudo Hospital Sint-Truiden Belgium Chronic aorto-iliac

More information

What is Vascular Surgery Worth to a Health Care System?

What is Vascular Surgery Worth to a Health Care System? What is Vascular Surgery Worth to a Health Care System? Peter Gloviczki, MD Robert Zwolak, MD Sean Roddy, MD Conflict of Interest NONE Mayo Clinic, Rochester, MN, Dartmouth-Hitchcock Medical Center, Lebanon,

More information

Ultrasound in Vascular Surgery. Torbjørn Dahl

Ultrasound in Vascular Surgery. Torbjørn Dahl Ultrasound in Vascular Surgery Torbjørn Dahl 1 The field of vascular surgery Veins dilatation and obstruction (varicose veins and valve dysfunction) Arteries dilatation and narrowing (aneurysms and atherosclerosis)

More information

Non-surgical treatment of severe varicose veins

Non-surgical treatment of severe varicose veins Non-surgical treatment of severe varicose veins Yasu Harasaki UCHSC Department of Surgery General Surgery Grand Rounds March 19, 2007 Definition Dilated, palpable, subcutaneous veins generally >3mm in

More information

Your Guide to Express Critical Illness Insurance Definitions

Your Guide to Express Critical Illness Insurance Definitions Your Guide to Express Critical Illness Insurance Definitions Your Guide to EXPRESS Critical Illness Insurance Definitions This guide to critical illness definitions will help you understand the illnesses

More information

Imaging of Thoracic Endovascular Stent-Grafts

Imaging of Thoracic Endovascular Stent-Grafts Imaging of Thoracic Endovascular Stent-Grafts Tariq Hameed, M.D. Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana Disclosures: No relevant financial

More information

Venous Reflux Disease and Current Treatments VN20-87-A 01/06

Venous Reflux Disease and Current Treatments VN20-87-A 01/06 Venous Reflux Disease and Current Treatments Leg Vein Anatomy Your legs are made up of a network of veins and vessels that carry blood back to the heart The venous system is comprised of: Deep veins Veins

More information

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Lower extremity artery disease. Erich Minar Medical University Vienna

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Lower extremity artery disease. Erich Minar Medical University Vienna ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Lower extremity artery disease Erich Minar Medical University Vienna for the Task Force on the Diagnosis and Treatment of Peripheral

More information

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY Dr. Mahesh Vakamudi Professor and Head Department of Anesthesiology, Critical Care and Pain Medicine Sri Ramachandra University INTRODUCTION

More information

Endovascular Repair of an Axillary Artery Aneurysm: A Novel Approach

Endovascular Repair of an Axillary Artery Aneurysm: A Novel Approach Endovascular Repair of an Axillary Artery Aneurysm: A Novel Approach Bao- Thuy D. Hoang, MD 1, Jonathan- Hien Vu, MD 2, Jerry Matteo, MD 3 1 Department of Surgery, University of Florida College of Medicine,

More information

Provided by the American Venous Forum: veinforum.org

Provided by the American Venous Forum: veinforum.org CHAPTER 17 SURGICAL THERAPY FOR DEEP VALVE INCOMPETENCE Original author: Seshadri Raju Abstracted by Gary W. Lemmon Introduction Deep vein valvular incompetence happens when the valves in the veins (tubes

More information

Majestic Trial 12 Month Results

Majestic Trial 12 Month Results Majestic Trial 12 Month Results S.Müller-Hülsbeck, MD, EBIR, FCIRSE, FICA ACADEMIC HOSPITALS Flensburg of Kiel University Ev.-Luth. Diakonissenanstalt zu Flensburg Knuthstraße 1, 24939 FLENSBURG Dept.

More information

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38 Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac

More information

Medicare C/D Medical Coverage Policy

Medicare C/D Medical Coverage Policy Varicose Vein Treatment Medicare C/D Medical Coverage Policy Origination Date: June 1, 1993 Review Date: September 16, 2015 Next Review: September, 2017 DESCRIPTION OF PROCEDURE OR SERVICE Varicose veins

More information

CMS Limitations Guide - Radiology Services

CMS Limitations Guide - Radiology Services CMS Limitations Guide - Radiology Services Starting October 1, 2015, CMS will update their existing medical necessity limitations on tests and procedures to correspond to ICD-10 codes. This limitations

More information

Lifecheque Basic Critical Illness Insurance

Lifecheque Basic Critical Illness Insurance Lifecheque Basic Critical Illness Insurance Strong. Reliable. Trustworthy. Forward-thinking. Extra help on the road to recovery Surviving a critical illness can be very challenging financially Few of us

More information

WHY DO MY LEGS HURT? Veins, arteries, and other stuff.

WHY DO MY LEGS HURT? Veins, arteries, and other stuff. WHY DO MY LEGS HURT? Veins, arteries, and other stuff. Karl A. Illig, MD Professor of Surgery Chief, Division of Vascular Surgery Mitzi Ekers, ARNP April 2013 Why do my legs hurt? CONFLICTS OF INTEREST

More information

Col league. SMMC Vascular Center Opens A PUBLICATION FOR SOUTHERN MAINE PHYSICIANS

Col league. SMMC Vascular Center Opens A PUBLICATION FOR SOUTHERN MAINE PHYSICIANS A PUBLICATION FOR SOUTHERN MAINE PHYSICIANS Col league 8 2012 SMMC Vascular Center Opens By Frank Lavoie, MD, Executive Vice President and Chief Operating Officer During the last year, Southern Maine Medical

More information

MEDICAL COVERAGE POLICY. SERVICE: Varicose Veins of the Lower Extremities. PRIOR AUTHORIZATION: Required.

MEDICAL COVERAGE POLICY. SERVICE: Varicose Veins of the Lower Extremities. PRIOR AUTHORIZATION: Required. Page 1 of 5 MEDICAL COVERAGE POLICY Important note Even though this policy may indicate that a particular service or supply may be considered covered, this conclusion is not based upon the terms of your

More information

AORTOENTERIC FISTULA. Mark H. Tseng MD Brooklyn VA Hospital February 11, 2005

AORTOENTERIC FISTULA. Mark H. Tseng MD Brooklyn VA Hospital February 11, 2005 AORTOENTERIC FISTULA Mark H. Tseng MD Brooklyn VA Hospital February 11, 2005 AORTOENTERIC FISTULA diagnosis and management Mark H. Tseng MD Brooklyn VA Hospital February 11, 2005 AORTOENTERIC FISTULA Aortoenteric

More information

Guidelines for the Management of Patients Following Endoluminal Vein Dilation Procedures for the Treatment of Multiple Sclerosis

Guidelines for the Management of Patients Following Endoluminal Vein Dilation Procedures for the Treatment of Multiple Sclerosis Guidelines for the Management of Patients Following Endoluminal Vein Dilation Procedures for the Treatment of Multiple Sclerosis Report Submitted to the Minister of Health and Long-Term Care By the Ontario

More information

Renovascular Disease. Renal Artery and Arteriosclerosis

Renovascular Disease. Renal Artery and Arteriosclerosis Other names: Renal Artery Stenosis (RAS) Renal Vascular Hypertension (RVH) Renal Artery Aneurysm (RAA) How does the normal kidney work? The blood passes through the kidneys to remove the body s waste.

More information

PROVIDER POLICIES & PROCEDURES

PROVIDER POLICIES & PROCEDURES PROVIDER POLICIES & PROCEDURES SCLEROTHERAPY TREATMENT OF SUPERFICIAL VARICOSE VEINS OF THE LEGS The purpose of this document is to provide guidance to providers enrolled in the Connecticut Medical Assistance

More information

treatment of varicose and spider veins patient information SAMPLE a publication by advancing vein care

treatment of varicose and spider veins patient information SAMPLE a publication by advancing vein care treatment of varicose and spider veins patient information a publication by advancing vein care Since most veins lie deep to the skin s surface, vein disorders are not always visible to the naked eye.

More information

Suffering from varicose veins? Patient Information. ELVeS Radial Minimally invasive laser therapy of venous insufficiency

Suffering from varicose veins? Patient Information. ELVeS Radial Minimally invasive laser therapy of venous insufficiency Suffering from varicose veins? Patient Information ELVeS Radial Minimally invasive laser therapy of venous insufficiency Do you suffer from heavy legs or visible veins? This makes diseases of the veins

More information

OHTAC Recommendation

OHTAC Recommendation OHTAC Recommendation Multiple Sclerosis and Chronic Cerebrospinal Venous Insufficiency Presented to the Ontario Health Technology Advisory Committee in May 2010 May 2010 Issue Background A review on the

More information

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012 Faculty Prevention Sharon Ewer, RN, BSN, CNRN Stroke Program Coordinator Baptist Health Montgomery, Alabama Satellite Conference and Live Webcast Monday, May 21, 2012 2:00 4:00 p.m. Central Time Produced

More information

Spotlight Series: Interventional Radiology. Varicose Veins and Venous Insufficiency

Spotlight Series: Interventional Radiology. Varicose Veins and Venous Insufficiency Spotlight Series: Interventional Radiology Varicose Veins and Venous Insufficiency What is venous insufficiency? Spectrum of Disease Spider veins and telangiectasias Small reddish and purple veins near

More information

Complications of Femoral Catheterization. Daniel Kaufman, MD University Hospital of Brooklyn December 16, 2005

Complications of Femoral Catheterization. Daniel Kaufman, MD University Hospital of Brooklyn December 16, 2005 Complications of Femoral Catheterization Daniel Kaufman, MD University Hospital of Brooklyn December 16, 2005 Case Presentation xx yr old female presents with fever, chills, and painful swelling of R groin

More information

Understanding Varicose Veins

Understanding Varicose Veins Understanding Varicose Veins Professor Bruce Campbell Published by Family Doctor Publications Limited in association with the British Medical Association IMPORTANT NOTICE This book is intended not as a

More information

VARICOSE VEINS. Information Leaflet. Your Health. Our Priority. VTE Ambulatory Clinic Stepping Hill Hospital

VARICOSE VEINS. Information Leaflet. Your Health. Our Priority. VTE Ambulatory Clinic Stepping Hill Hospital VARICOSE VEINS Information Leaflet Your Health. Our Priority. Page 2 of 7 Varicose Veins There are no accurate figures for the number of people with varicose veins. Some studies suggest that 3 in 100 people

More information

Vascular Laboratory Education and Training

Vascular Laboratory Education and Training Vascular Laboratory Education and Training David L. Dawson, MD, RVT, RPVI Vascular laboratory professionals technologists and physicians have specific knowledge and expertise in the use of non- invasive

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

A Patient s Guide to Minimally Invasive Abdominal Aortic Aneurysm Repair

A Patient s Guide to Minimally Invasive Abdominal Aortic Aneurysm Repair A Patient s Guide to Minimally Invasive Abdominal Aortic Aneurysm Repair Table of Contents The AFX Endovascular AAA System............................................ 1 What is an Abdominal Aortic Aneurysm

More information

LOWER EXTREMITY VENOUS DUPLEX ULTRASOUND:

LOWER EXTREMITY VENOUS DUPLEX ULTRASOUND: LOWER EXTREMITY VENOUS DUPLEX ULTRASOUND: Chronic Venous Insufficiency Phillip J Bendick, PhD William Beaumont Hospital Royal Oak, Michigan Prevalence: Carotid ASO ~ 3M Peripheral Arterial Dz ~ 5M + CAD

More information

Medicare C/D Medical Coverage Policy

Medicare C/D Medical Coverage Policy Varicose Vein Treatment Origination Date: June 1, 1993 Review Date: July 20, 2016 Next Review: July, 2018 Medicare C/D Medical Coverage Policy DESCRIPTION OF PROCEDURE OR SERVICE Varicose veins of the

More information

Duration of Dual Antiplatelet Therapy After Coronary Stenting

Duration of Dual Antiplatelet Therapy After Coronary Stenting Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are

More information

Process Representation #1 : The PAD algorithm as a sequential flow thru all sections

Process Representation #1 : The PAD algorithm as a sequential flow thru all sections Process Representation #1 : The PAD algorithm as a sequential flow thru all sections An exploded version of the above scoped section flow is shown below. Notes: The flow presupposes existing services (

More information

TREATMENT OF VARICOSE AND SPIDER VEINS Patient Info

TREATMENT OF VARICOSE AND SPIDER VEINS Patient Info TREATMENT OF VARICOSE AND SPIDER VEINS Patient Info www.heartofthevillages.com TIRED & ACHING LEGS? If you suffer from varicose and spider veins, you are not alone. It is estimated that there are more

More information

Investor News. Not intended for U.S. and UK media

Investor News. Not intended for U.S. and UK media Investor News Not intended for U.S. and UK media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer s Xarelto (Rivaroxaban) Approved for the Treatment of Pulmonary Embolism

More information

CARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN

CARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN HOSPITALIZATION CASE #: 2 8 8 0 H FY288BH4CN Has the participant indicated any of the following reasons for being admitted overnight for this case? 1. Suspected or confirmed problems with the heart, circulation,

More information

PARTICULAR ASPECTS OF ANTI-THROMBOTIC TREATMENT IN HIP ARTHROPLASTY

PARTICULAR ASPECTS OF ANTI-THROMBOTIC TREATMENT IN HIP ARTHROPLASTY 1 UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA PARTICULAR ASPECTS OF ANTI-THROMBOTIC TREATMENT IN HIP ARTHROPLASTY ABSTRACT Ph.D student DR. TRUŞCĂ PAUL TIBERIU SCIENTIFIC COORDONATOR PROF. DR.VALENTIN

More information

Venous Thromboembolic Treatment Guidelines

Venous Thromboembolic Treatment Guidelines Venous Thromboembolic Treatment Guidelines About the NYU Venous Thromboembolic Center (VTEC) The center s mission is to deliver advanced screening, detection, care, and management services for patients

More information

Talent Thoracic Stent Graft with THE Xcelerant Delivery System. Expanding the Indications for TEVAR

Talent Thoracic Stent Graft with THE Xcelerant Delivery System. Expanding the Indications for TEVAR Talent Thoracic with THE Xcelerant Delivery System Expanding the Indications for TEVAR Talent Thoracic Precise placement 1 Broad patient applicability 1 Excellent clinical outcomes 1, a + Xcelerant Delivery

More information

Term Critical Illness Insurance

Term Critical Illness Insurance Term Critical Illness Insurance PRODUCT GUIDE 5368-01A-JUL14 ASSUMPTION LIFE This document is a summary of the various features of Assumption Life's products. It is neither a contract nor an insurance

More information

Recurrent Varicose Veins

Recurrent Varicose Veins Information for patients Recurrent Varicose Veins Sheffield Vascular Institute Northern General Hospital You have been diagnosed as having Varicose Veins that have recurred (come back). This leaflet explains

More information

Renovascular Hypertension

Renovascular Hypertension Renovascular Hypertension Philip Stockwell, MD Assistant Professor of Medicine (Clinical) Warren Alpert School of Medicine Cardiology for the Primary Care Provider September 28, 201 Renovascular Hypertension

More information

Vascular Technology (VT) Content Outline Anatomy & physiology 20% Cerebrovascular Cerebrovascular normal anatomy Evaluate the cerebrovascular vessels

Vascular Technology (VT) Content Outline Anatomy & physiology 20% Cerebrovascular Cerebrovascular normal anatomy Evaluate the cerebrovascular vessels Vascular Technology (VT) Content Outline Anatomy & physiology 20% normal anatomy Evaluate the cerebrovascular vessels hemodynamics Evaluate the cerebrovascular vessels for normal perfusion normal anatomy

More information

Delineation of Privileges Department of Surgery/Section of Vascular Surgery. Name: Please print or type

Delineation of Privileges Department of Surgery/Section of Vascular Surgery. Name: Please print or type University of Michigan Hospitals and Health Centers Delineation of Privileges Department of Surgery/Section of Vascular Surgery Name: Please print or type CORE PRIVILEGES VASCULAR SURGEON Vascular Surgery

More information

Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of Unmet Medical Need in Arterial Thromboembolism

Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of Unmet Medical Need in Arterial Thromboembolism Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of

More information

RADIOLOGY 2014 CPT Codes

RADIOLOGY 2014 CPT Codes RADIOLOGY 2014 CPT Codes Radiology 2014 CPT Codes CMS has issued 36 new procedure codes (one is a radiation therapy code) for CY 2014 that directly pertain to radiology with 26 of those codes the result

More information

Patient Information Booklet. Endovascular Stent Grafts: A Treatment for Abdominal Aortic Aneurysms

Patient Information Booklet. Endovascular Stent Grafts: A Treatment for Abdominal Aortic Aneurysms Patient Information Booklet Endovascular Stent Grafts: A Treatment for Abdominal Aortic Aneurysms TABLE OF CONTENTS Introduction 1 Glossary 2 Abdominal Aorta 4 Abdominal Aortic Aneurysm 5 Causes 6 Symptoms

More information

Trust Guideline for Thromboprophylaxis in Trauma and Orthopaedic Inpatients

Trust Guideline for Thromboprophylaxis in Trauma and Orthopaedic Inpatients A clinical guideline recommended for use In: By: For: Key words: Department of Orthopaedics, NNUHT Medical staff Trauma & Orthopaedic Inpatients Deep vein thrombosis, Thromboprophylaxis, Orthopaedic Surgery

More information

Listen to your heart: Good Cardiovascular Health for Life

Listen to your heart: Good Cardiovascular Health for Life Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular

More information

ABOUT XARELTO CLINICAL STUDIES

ABOUT XARELTO CLINICAL STUDIES ABOUT XARELTO CLINICAL STUDIES FAST FACTS Xarelto (rivaroxaban) is a novel, oral direct Factor Xa inhibitor. On September 30, 2008, the European Commission granted marketing approval for Xarelto for the

More information

SEDICO Newsletter Issue 8. Varicose veins

SEDICO Newsletter Issue 8. Varicose veins SEDICO Newsletter Issue 8 Definition: Varicose veins Varicose veins are veins that have become enlarged and twisted. The term commonly refers to the veins on the leg, although varicose veins occur elsewhere.

More information

Position Statement: The Use of VTED Prophylaxis in Foot and Ankle Surgery

Position Statement: The Use of VTED Prophylaxis in Foot and Ankle Surgery Position Statement: The Use of VTED Prophylaxis in Foot and Ankle Surgery Position Statement There is currently insufficient data for the (AOFAS) to recommend for or against routine VTED prophylaxis for

More information

Venous and Lymphatic Disorders

Venous and Lymphatic Disorders Venous and Lymphatic Disorders. ก. Venous and Lymphatic Disorders Varicose Veins Deep Vein Thrombosis (DVT) Lymphedema What Is Varicose Veins? Latin: Varicose = Varix = twisted Abnormal venous dilatation

More information

Recurrent Varicose Veins. Vineet Mishra, MD Director of Mohs Surgery and Procedural Dermatology University of Texas Health Science Center San Antonio

Recurrent Varicose Veins. Vineet Mishra, MD Director of Mohs Surgery and Procedural Dermatology University of Texas Health Science Center San Antonio Recurrent Varicose Veins Vineet Mishra, MD Director of Mohs Surgery and Procedural Dermatology University of Texas Health Science Center San Antonio Disclosures None Possible Causes of Recurrence DNA:

More information

Understanding your Renal Stent Procedure. A patient Guide (COVER PAGE) TABLE OF CONTENTS (inside front page)

Understanding your Renal Stent Procedure. A patient Guide (COVER PAGE) TABLE OF CONTENTS (inside front page) Understanding your Renal Stent Procedure. A patient Guide (COVER PAGE) TABLE OF CONTENTS (inside front page) The Kidney and the Renal Arteries... 1 Renal Artery Disease... 2 Diagnosis of Renal.Artery Disease...

More information

The Bioresorbable Vascular Stent Dr Albert Ko

The Bioresorbable Vascular Stent Dr Albert Ko The Bioresorbable Vascular Stent Dr Albert Ko Dr Albert Ko MB BS, FRACP, FCSANZ Interventional/General Cardiologist Ascot Cardiology Symposium 2013 Treatment Goals for Coronary Artery Disease Relieve of

More information

Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism ERRATUM

Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism ERRATUM Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism ERRATUM This report was commissioned by the NIHR HTA Programme as project number 12/78

More information

Varicose veins - 1 -

Varicose veins - 1 - Varicose veins - 1 - Varicose Veins About 3 in 10 adults develop varicose veins at some time in their life. Most people with varicose veins do not have an underlying disease and they usually occur for

More information

Dialysis Vascular Access Coverage, Coding and Reimbursement Overview Physician / Hospital / ASC

Dialysis Vascular Access Coverage, Coding and Reimbursement Overview Physician / Hospital / ASC Dialysis Vascular Access Coverage, Coding and Reimbursement Overview Physician / Hospital / ASC 2015 Edition All Reimbursement Amounts are Listed at National Rates and Do Not Include the 2% Sequestration

More information

Cilostazol versus Clopidogrel after Coronary Stenting

Cilostazol versus Clopidogrel after Coronary Stenting Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background

More information

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients

More information

Inferior Vena Cava filter and removal

Inferior Vena Cava filter and removal Inferior Vena Cava filter and removal What is Inferior Vena Cava Filter Placement and Removal? An inferior vena cava filter placement procedure involves an interventional radiologist (a specialist doctor)

More information

1. Utility of transradial approach in endovascular management of chronic mesenteric ischemia

1. Utility of transradial approach in endovascular management of chronic mesenteric ischemia PUBLICATIONS, ABSTRACTS AND PRESENTATIONS : 1. Utility of transradial approach in endovascular management of chronic mesenteric ischemia 2. Endovascular management of the suprarenal IVC agenesis 3. The

More information

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence

Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Guidelines Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Stroke/TIA Nearly 700,000 ischemic strokes and 240,000 TIAs every year in the United States Currently, the risk for

More information

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,

More information

RANDOMIZED CONTROL TRIALS (RCT s) on VARICOSE VEIN ENDOVENOUS TREATMENT

RANDOMIZED CONTROL TRIALS (RCT s) on VARICOSE VEIN ENDOVENOUS TREATMENT RANDOMIZED CONTROL TRIALS (RCT s) on VARICOSE VEIN ENDOVENOUS TREATMENT M. PERRIN Lyon - France CONTROVERSIES AND UPDATES IN VASCULAR SURGERY JANUARY 19-21, 2012 Paris B. Eklof Helsingborg, Sweden Thirty

More information

REPORTING STENT PLACEMENT FOR NONOCCLUSIVE VASCULAR DISEASE IN LOWER EXTREMITIES

REPORTING STENT PLACEMENT FOR NONOCCLUSIVE VASCULAR DISEASE IN LOWER EXTREMITIES REPORTING STENT PLACEMENT FOR NONOCCLUSIVE VASCULAR DISEASE IN LOWER EXTREMITIES Effective January 1, 2015, there was a change in CPT that affects reporting specific endovascular services provided in the

More information

Cardiovascular diseases. pathology

Cardiovascular diseases. pathology Cardiovascular diseases pathology Atherosclerosis Vascular diseases A disease that results in arterial wall thickens as a result of build- up of fatty materials such cholesterol, resulting in acute and

More information

Patients suffering from critical limb ischemia (CLI)

Patients suffering from critical limb ischemia (CLI) Building a Successful Amputation Prevention Program Our single-center experience implementing an amputation prevention algorithm and how it has led to a trend in reduced amputation rates. By Jihad A. Mustapha,

More information

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.

More information

Gruppo di lavoro: Malattie Tromboemboliche

Gruppo di lavoro: Malattie Tromboemboliche Gruppo di lavoro: Malattie Tromboemboliche 2381 Soluble Recombinant Thrombomodulin Ameliorates Hematological Malignancy-Induced Disseminated Intravascular Coagulation More Promptly Than Conventional Anticoagulant

More information

CHAPTER 15 SCLEROTHERAPY FOR VENOUS DISEASE

CHAPTER 15 SCLEROTHERAPY FOR VENOUS DISEASE Introduction CHAPTER 15 SCLEROTHERAPY FOR VENOUS DISEASE Original authors: Niren Angle, John J. Bergan, Joshua I. Greenberg, and J. Leonel Villavicencio Abstracted by Teresa L. Carman New technology has

More information

Registered Charity No: 326679 Caring for those with a rare, complex and lifelong disease www.behcets.org.uk

Registered Charity No: 326679 Caring for those with a rare, complex and lifelong disease www.behcets.org.uk Registered Charity No: 326679 Caring for those with a rare, complex and lifelong disease www.behcets.org.uk Behçet s Disease and the Kidneys How are the kidneys affected by Behçet s disease? Kidney disease

More information

INTRODUCTION TO EECP THERAPY

INTRODUCTION TO EECP THERAPY INTRODUCTION TO EECP THERAPY is an FDA cleared, Medicare approved, non-invasive medical therapy for the treatment of stable and unstable angina, congestive heart failure, acute myocardial infarction, and

More information

Overview. Total Joint Replacement in the U.S. KP National Total Joint Registry EMR Tools and Outcome Assessment: A Model for Vascular Surgery?

Overview. Total Joint Replacement in the U.S. KP National Total Joint Registry EMR Tools and Outcome Assessment: A Model for Vascular Surgery? KP National Total Joint Registry EMR Tools and Outcome Assessment: A Model for Vascular Surgery? Liz Paxton Director of Surgical Outcomes and Analysis Overview KP Total Joint Replacement Registry Background

More information

X-Plain Varicose Veins Reference Summary

X-Plain Varicose Veins Reference Summary X-Plain Varicose Veins Reference Summary Introduction Varicose veins are very common, in both women and men. Varicose veins can be painful and unattractive. Vein doctors use non-invasive ultrasound imaging

More information

Yes when meets criteria below

Yes when meets criteria below Vein Disease Treatment MP9241 Covered Service: Prior Authorization Required: Additional Information: Medicare Policy: BadgerCare Plus Policy: Yes when meets criteria below Yes None Dean Health Plan covers

More information

Effective Date: March 2, 2016

Effective Date: March 2, 2016 Medical Review Criteria Varicose Vein Procedures Effective Date: March 2, 2016 Treatmetn Subject: Varicose Vein Procedures VeinTreatment of Varicose Policy: Veins HPHC covers specific non-experimental

More information

Modern Management of Varicose Veins

Modern Management of Varicose Veins Modern Management of Varicose Veins GPCME 2008 David Ferrar Vascular and Endovascular Surgeon Vascular Ultrasound Specialist Multimodality treatment Compression stockings Sclerotherapy Ultrasound guided

More information

What Does Pregnancy Have to Do With Blood Clots in a Woman s Legs?

What Does Pregnancy Have to Do With Blood Clots in a Woman s Legs? Patient s Guide to Prevention of Blood Clots During Pregnancy: Use of Blood-Thinning A Patient s Guide to Prevention of Blood Clots During Pregnancy: Use of Blood-Thinning Drugs to Prevent Abnormal Blood

More information

Stent for Life Initiative How can we improve system delay and patients delay in STEMI

Stent for Life Initiative How can we improve system delay and patients delay in STEMI Stent for Life Initiative How can we improve system delay and patients delay in STEMI Z. Kaifoszova SFL Initiative Europe 2011 Stent for Life Initiative 10 countries participate in the program Declaration

More information

PATIENT INFORMATION BOOKLET

PATIENT INFORMATION BOOKLET PATIENT INFORMATION BOOKLET Wingspan Stent System with Gateway PTA Balloon Catheter TABLE OF CONTENTS Definitions... 2 What is the Purpose of This Booklet?... 3 What is an Intracranial Lesion?... 3 Who

More information

Rivaroxaban for acute coronary syndromes

Rivaroxaban for acute coronary syndromes Northern Treatment Advisory Group Rivaroxaban for acute coronary syndromes Lead author: Nancy Kane Regional Drug & Therapeutics Centre (Newcastle) May 2014 2014 Summary Current long-term management following

More information

Provided by the American Venous Forum: veinforum.org

Provided by the American Venous Forum: veinforum.org CHAPTER 1 NORMAL VENOUS CIRCULATION Original author: Frank Padberg Abstracted by Teresa L.Carman Introduction The circulatory system is responsible for circulating (moving) blood throughout the body. The

More information

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia INTRODUCTION Thrombophilia (Hypercoagulability) is a condition in which a person forms blood clots more than normal. Blood clots may occur in the arms or legs (e.g., deep vein thrombosis DVT), the lungs

More information

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) March 2014 2014 MVP Health Care, Inc. CHAPTER 9 CHAPTER SPECIFIC CATEGORY CODE BLOCKS I00-I02 Acute rheumatic fever I05-I09 Chronic rheumatic heart

More information

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below Name: generic (trade) Rivaroxaban (Xarelto ) HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below What it is Indications

More information

Description of the OECD Health Care Quality Indicators as well as indicator-specific information

Description of the OECD Health Care Quality Indicators as well as indicator-specific information Appendix 1. Description of the OECD Health Care Quality Indicators as well as indicator-specific information The numbers after the indicator name refer to the report(s) by OECD and/or THL where the data

More information

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media News Release Not intended for U.S. and UK Media Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer Forms Collaboration with Academic and Governmental Institutions for Rivaroxaban

More information

Clinical Review Criteria

Clinical Review Criteria Clinical Review Criteria Treatment of Varicose Veins Radiofrequency Catheter Closure Sclerotherapy Surgical Stripping Trivex System for Outpatient Varicose Vein Surgery VenaSeal Closure System VNUS Closure

More information

Curriculum Vitae. Shankar M. Sundaram, M.D., F.A.C.S., F.C.C.P. 9 Medical Parkway, Plaza 4, Suite 210 Dallas, Texas 75234

Curriculum Vitae. Shankar M. Sundaram, M.D., F.A.C.S., F.C.C.P. 9 Medical Parkway, Plaza 4, Suite 210 Dallas, Texas 75234 Curriculum Vitae Shankar M. Sundaram, M.D., F.A.C.S., F.C.C.P. 9 Medical Parkway, Plaza 4, Suite 210 Dallas, Texas 75234 Phone: Office 972-888-4500 Fax 972-488-9636 Cell 972-838-0984 E-mail: sms5217@yahoo.com

More information